These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Effect of prostacyclin and 6-keto-PGFl alpha on coronary vascular resistance]. Boroian RG Zh Eksp Klin Med; 1978; 18(4):40-4. PubMed ID: 360725 [No Abstract] [Full Text] [Related]
7. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro. Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451 [No Abstract] [Full Text] [Related]
8. Effect of different prostaglandin analogues on gastric acid secretion and mucosal blood flow in the dog: action on stimulated and resting mucosa. Bálint GA; Sági I; Döbrönte Z; Varró V Acta Med Hung; 1984; 41(2-3):149-55. PubMed ID: 6379594 [TBL] [Abstract][Full Text] [Related]
9. Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro. Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR Prostaglandins; 1978 Jun; 15(6):955-67. PubMed ID: 358297 [TBL] [Abstract][Full Text] [Related]
10. Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells. Soll AH J Clin Invest; 1980 May; 65(5):1222-9. PubMed ID: 6154063 [TBL] [Abstract][Full Text] [Related]
12. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems. Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109 [No Abstract] [Full Text] [Related]
14. Inhibition of acid secretion in isolated canine parietal cells by prostaglandins. Skoglund ML; Nies AS; Gerber JG J Pharmacol Exp Ther; 1982 Feb; 220(2):371-4. PubMed ID: 6799643 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems. Kawasaki A; Ishii K; Wakitani K; Tsuboshima M Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531 [No Abstract] [Full Text] [Related]
16. Interrelationships between the chemical structure of prostanoids and prostacyclins and their cytoprotective effects on the ethanol-induced gastric mucosal damage in rats (a comparative experimental study). Székely I; Jávor T; Kovács G; Botár S; Morón F; Mózsik G Acta Physiol Hung; 1984; 64(3-4):231-5. PubMed ID: 6397964 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship (SAR) among prostacyclin (PGI2) analogues. Kovács G; Székely I; Stadler I; Körmöczy P Acta Physiol Hung; 1984; 64(3-4):225-30. PubMed ID: 6397963 [TBL] [Abstract][Full Text] [Related]
18. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs. Konturek SJ Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360 [No Abstract] [Full Text] [Related]
19. Prostaglandins as ocular hypotensive agents; development of an analogue for glaucoma treatment. Stjernschantz J Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():63-8. PubMed ID: 7732906 [No Abstract] [Full Text] [Related]
20. Dual actions of prostacyclin (PGI2) on the rat pregnant uterus. Williams KI; El-Tahir KE; Marcinkiewicz E Prostaglandins; 1979 May; 17(5):667-72. PubMed ID: 386426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]